Celldex 制药 CLDX
$29.87 +$1.60 (+5.66%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $30.00 +0.44%
开盘$27.85
昨收$28.27
当日区间$27.82 – $30.15
成交量926.3K
市值$2.35B
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例117.3%+5.98 个百分点，较上季度
持仓机构数304-2 ，较上季度
内部人近期交易44次买入 / 6次卖出净买入
空头持仓比例12.22% 占流通股回补天数 5.9 · 截至 15 Oct 2026
卖空成交量占比20.5%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$4.54M（10个净流入日，10个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有44.5%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从9.72%升至12.22%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| FMR | Mutual Fund | 2026/Q3 | +4,689,017 | 10.7% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +383,874 | 0.7% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +2,599,855 | 6.0% |
| Deep Track Capital, LP | VC/PE Fund | 2026/Q3 | +1,655,172 | 3.7% |
| Logos Global Management, L.P. | Hedge Fund | 2026/Q3 | +1,650,000 | 2.7% |
| BlackRock | Mutual Fund | 2026/Q3 | +1,632,645 | 8.9% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +1,096,259 | 5.0% |
| Driehaus Capital Management LLC | Mutual Fund | 2026/Q3 | +989,442 | 1.3% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +983,195 | 12.2% |
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +642,171 | 1.0% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +627,312 | 5.1% |
| Foresite Capital Management, LLC | VC/PE Fund | 2026/Q3 | +563,800 | 1.1% |
| Two Sigma Investments, LP | Hedge Fund | 2026/Q3 | +524,220 | 0.8% |
| Baker Bros. Advisors LP | Hedge Fund | 2026/Q3 | +517,241 | 1.5% |
| Federated Hermes, Inc. | Mutual Fund | 2026/Q3 | +492,893 | 0.6% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 24 Jun 2026 | Harry Penner | Chairperson | Other Derivative Acquisition | +26,000 | $34.09 | 26,000 |
| 24 Jun 2026 | Herbert Conrad | Independent Director | Other Derivative Acquisition | +26,000 | $34.09 | 26,000 |
| 24 Jun 2026 | James Marino | Independent Director | Other Derivative Acquisition | +26,000 | $34.09 | 26,000 |
| 24 Jun 2026 | Ronald Pepin | Chief Business Officer & Senior VP | Other Derivative Acquisition | +20,000 | $34.09 | 20,000 |
| 24 Jun 2026 | Anthony Marucci | Chief Executive Officer | Other Derivative Acquisition | +375,000 | $34.09 | 375,000 |
| 24 Jun 2026 | Tibor Keler | Founder, Chief Scientific Officer & Executive VP | Other Derivative Acquisition | +115,000 | $34.09 | 115,000 |
| 24 Jun 2026 | Diane Young | Senior VP & Chief Medical Officer | Other Derivative Acquisition | +57,000 | $34.09 | 57,000 |
| 24 Jun 2026 | Sarah Cavanaugh | Senior Vice President of Corporate Affairs & Administration | Other Derivative Acquisition | +95,000 | $34.09 | 95,000 |
| 24 Jun 2026 | Garry Neil | Independent Director | Other Derivative Acquisition | +26,000 | $34.09 | 26,000 |
| 24 Jun 2026 | Keith Brownlie | Independent Director | Other Derivative Acquisition | +26,000 | $34.09 | 26,000 |
| 24 Jun 2026 | Cheryl Cohen | Independent Director | Other Derivative Acquisition | +26,000 | $34.09 | 26,000 |
| 24 Jun 2026 | Elizabeth Crowley | Chief Product Development Officer & Senior VP | Other Derivative Acquisition | +100,000 | $34.09 | 100,000 |
| 24 Jun 2026 | Rita Jain | Independent Director | Other Derivative Acquisition | +26,000 | $34.09 | 26,000 |
| 24 Jun 2026 | Sam Martin | Senior VP, CFO, Secretary & Treasurer | Other Derivative Acquisition | +93,000 | $34.09 | 93,000 |
| 24 Jun 2026 | Margo Heath-Chiozzi | Senior Vice President of Regulatory Affairs | Other Derivative Acquisition | +95,000 | $34.09 | 95,000 |
| 24 Jun 2026 | Denice Torres | Independent Director | Other Derivative Acquisition | +26,000 | $34.09 | 26,000 |
| 24 Jun 2026 | Freddy Jimenez | General Counsel | Other Derivative Acquisition | +93,000 | $34.09 | 93,000 |
| 24 Jun 2026 | Teri Lawver | SVP & Chief Commercial Officer | Other Derivative Acquisition | +90,000 | $34.09 | 90,000 |
| 1 Jan 2026 | Sam Martin | Senior VP, CFO, Secretary & Treasurer | Derivative Exercise and Retained | +4,817 | $10.38 | 32,942 |
| 14 Dec 2025 | Ronald Pepin | Chief Business Officer & Senior VP | Derivative Exercise and Retained | +19,333 | $9.02 | 20,097 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 9,598,891 | 12.2% | 5.9 |
| 30 Sep 2026 | 11,006,720 | 14.0% | 3.8 |
| 15 Sep 2026 | 8,953,127 | 11.4% | 13.1 |
| 31 Aug 2026 | 8,641,597 | 11.0% | 12.2 |
| 14 Aug 2026 | 7,569,702 | 9.6% | 7.9 |
| 31 Jul 2026 | 7,627,081 | 9.7% | 7.6 |
暂无评论——快来第一个聊聊 CLDX。
登录后参与讨论。